Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Natural Liushen Pill (天然六神丸) is a premium traditional Chinese medicine (TCM) formulation developed and manufactured by Changshu Leiyunshang Pharmaceutical, a subsidiary of Leiyunshang Pharmaceutical Group. It is a high-end variant of the classic Liushen Pill, uniquely formulated with six precious natural ingredients: natural musk (sourced from the endangered musk deer under strict national quotas), bezoar, toad venom, realgar, borneol, and pearl. The pill is widely recognized for its potent anti-inflammatory, analgesic, antibacterial, and antiviral properties. It is primarily indicated for the treatment of acute pharyngitis, tonsillitis, sore throat, and various inflammatory skin conditions. Due to the presence of toad venom and realgar, which carry potential toxicity, and natural musk, which can induce uterine contractions, the medication is contraindicated in pregnant women and must be used with caution under medical supervision.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Natural Liushen Pill.